Concepedia

Ardaman Shergill

AS

Statistics

Publications

30

Citations

3.5K

H-Index

21

Active since

2006

Affiliations

University of Chicago(Current)

Memorial Sloan Kettering Cancer Center

Mayo Clinic

Dana-Farber Cancer Institute

University of Chicago Medical Center

Ardaman Shergill is an author at University of Chicago specializing in oncology, medicine, and surgical oncology.

ORCID

Publications per year

2006–2025

30

Publications

30

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah et al. · The Lancet · 2020 · 1.8K citations · Full text

, , +8

Preoperative Treatment of Locally Advanced Rectal Cancer

Deborah Schrag, Qian Shi, Martin R. Weiser et al. · New England Journal of Medicine · 2023 · 448 citations · Full text

, , +17

Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study

Arvind Dasari, Sara Lonardi, Rocio García‐Carbonero et al. · The Lancet · 2023 · 323 citations · Full text

, , +9

Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors

Jennifer A. Chan, Susan M. Geyer, Tyler Zemla et al. · New England Journal of Medicine · 2024 · 136 citations · Full text

, , +9

A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results

Amy Rappaport, Chrisann Kyi, Monica Lane et al. · Nature Medicine · 2024 · 127 citations

, , +17

1–5 of 30